Measurement of syndecan-1 levels in sepsis patients might be useful for identifying patients at high risk of organ dysfunction and mortality as well as those who could benefit from therapies targeted at protecting or restoring the glycocalyx.
Together, these findings suggest that measurement of syndecan-1 levels in patients with sepsis may be useful for identifying patients at high risk of organ dysfunction and mortality and those who may benefit from therapies targeted at protecting or restoring the glycocalyx.
Finally, given that a predefined level of MAP does not guarantee an adequate perfusion pressure to all tissues and cannot be generalized to all patients, hemodynamic resuscitation should be targeted not only at restoring perfusion pressure but also at providing a sufficient oxygen delivery to guarantee an adequate cellular metabolism [ 2].
These limitations need to be explicitly acknowledged when designing management strategies and policies as they seriously constrain our ability to identify relevant conservation targets aimed at restoring or reversing biodiversity losses.
On the contrary, a tailored MAP target aiming at restoring tissue perfusion, based on assessment of mental status, skin appearance, urinary output and perhaps CEUS parameters could represent an alternative approach [ 30].
Here, we provide an overview of current research focused on the relevance of autophagic/lysosomal dysfunction in AD pathogenesis as well as potential therapeutic targets aimed at restoring autophagic/lysosomal pathway function.
But Ride New Orleans, a transit rider organization, says streetcar rides targeted at tourists are fully restored but bus service for regular people is way down, still only at 35percentt of what it was before Katrina.
Conceivably, individuals with an unfavourable pro:mature domain ratio could be targeted with therapy aimed at restoring a more neurotrophic environment in the brain.
The therapeutic strategies targeting kinesin proteins or those aiming at restoring metallothionein expression, such as histone deacetylase inhibitors, deserve further study in these tumours.
Well, the President has those too -- remember the $716 billion of Medicare savings targeted at providers that was the rage a few weeks ago (and that Gov. Romney says he'll restore)?
